Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?

Overview of attention for article published in Frontiers in Pediatrics, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 4,711 followers.

RT @FrontPediatrics: New Research: Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?: Introductio…

04 Jan 2022

Reply Repost Favourite

RT @FrontPediatrics: New Research: Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?: Introductio…

04 Jan 2022

Reply Repost Favourite

New Research: Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?: Introduction: Familial Mediterranean fever (FMF) patients had 5–10% colchicine resistance. Although FMF attacks are characterized by… https://t.co/Kg

03 Jan 2022

Reply Repost Favourite

RT @drsameterden: Just accepted @FrontPediatrics @MdKucuksahin @armaganberkan @OmmaDr ''Serum endocan levels were higher in colchicine resi…

29 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.